PALO ALTO, Calif., Sept. 5, 2024
PALO ALTO, Calif., Sept. 5, 2024 /PRNewswire/ -- SageMedic Corp (also known as 'SAGE'), a Silicon Valley-based rising star in cancer diagnostics, is excited to announce the formation of its Scientific and Medical Advisory Board (SAB). Comprised of distinguished authorities in cancer research and medical and surgical oncology, the board reflects SageMedic's commitment to significantly enhance the precision of cancer diagnostics by enabling oncologists to more effectively tailor therapies to individual patient needs.
Advertisement
Chris Apfel, MD, MBA, Chair & CEO of SageMedic, expressed his enthusiasm: "We are honored to have such a prestigious group of key opinion leaders join our SAB. Their unparalleled expertise will continue to push the boundaries of what is possible in precision medicine to truly personalize therapies for cancer patients."
Advertisement
About SageMedic Corp:
SageMedic Corp is at the forefront of developing diagnostic solutions that significantly improve treatment outcomes in oncology. Through the innovative SAGE Oncotest™, an AI-augmented, in-vitro, live 3D microtumor approach, the company provides actionable insights that allow oncologists to devise personalized treatment strategies, enhancing the quality of life for cancer patients across the globe.
For inquiries or further information about SageMedic, please direct communications to:
Mara Quigley, Co-President, Steve Allen Media(661) [email protected]://SteveAllenMedia.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/sagemedic-corp-announces-formation-of-its-scientific-and-medical-advisory-board-to-significantly-advance-precision-medicine-for-cancer-patients-302239388.html
SOURCE SageMedic Corp
